Psychiatric Comorbidity and Greater Hospitalization Risk, Longer Length of Stay, and Higher Hospitalization Costs in Older Adults with Heart Failure by Sayers, Steven L et al.
University of Pennsylvania
ScholarlyCommons
School of Nursing Departmental Papers School of Nursing
10-2007
Psychiatric Comorbidity and Greater
Hospitalization Risk, Longer Length of Stay, and
Higher Hospitalization Costs in Older Adults with
Heart Failure
Steven L. Sayers
University of Pennsylvania
Nancy Hanrahan
Ann Kutney Lee
University of Pennsylvania
Sean P. Clarke
Brendali F. Reis
See next page for additional authors
Follow this and additional works at: https://repository.upenn.edu/nrs
Part of the Cardiology Commons, Cardiovascular Diseases Commons, Circulatory and
Respiratory Physiology Commons, Geriatrics Commons, Health and Medical Administration
Commons, Medical Humanities Commons, Nursing Commons, Psychiatry Commons, and the
Psychiatry and Psychology Commons
This paper is posted at ScholarlyCommons. https://repository.upenn.edu/nrs/169
For more information, please contact repository@pobox.upenn.edu.
Recommended Citation
Sayers, S. L., Hanrahan, N., Kutney Lee, A., Clarke, S. P., Reis, B. F., & Riegel, B. (2007). Psychiatric Comorbidity and Greater
Hospitalization Risk, Longer Length of Stay, and Higher Hospitalization Costs in Older Adults with Heart Failure. Journal of the
American Geriatrics Society, 55 (10), 1585-1591. http://dx.doi.org/10.1111/j.1532-5415.2007.01368.x
Psychiatric Comorbidity and Greater Hospitalization Risk, Longer Length
of Stay, and Higher Hospitalization Costs in Older Adults with Heart
Failure
Abstract
OBJECTIVES: To explore associations between psychiatric comorbidity and rehospitalization risk, length of
hospitalization, and costs.
DESIGN: Cross‐sectional study of 1‐year hospital administrative data.
SETTING: Claims‐based study of older adults hospitalized in the United States.
PARTICIPANTS: Twenty‐one thousand four hundred twenty‐nine patients from a 5% national random
sample of U.S. Medicare beneficiaries aged 65 and older, with at least one acute care hospitalization in 1999
with a Diagnostic‐Related Group of congestive heart failure.
MEASUREMENTS: The number of hospitalizations, mean length of hospital stay, and total hospitalization
costs in calendar year 1999.
RESULTS: Overall, 15.8% of patients hospitalized for heart failure (HF) had a coded psychiatric
comorbidity; the most commonly coded comorbid psychiatric disorder was depression (8.5% of the sample).
Most forms of psychiatric comorbidity were associated with greater inpatient utilization, including risk of
additional hospitalizations, days of stay, and hospitalization charges. Additional hospitalization costs
associated with psychiatric comorbidity ranged up to $7,763, and additional days length of stay ranged up to
1.4 days.
CONCLUSION: Psychiatric comorbidity appears in a significant minority of patients hospitalized for HF
and may affect their clinical and economic outcomes. The associations between psychiatric comorbidity and
use of inpatient care are likely to be an underestimate, because psychiatric illness is known to be
underdetected in older adults and in hospitalized medical patients.
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Abstract 1 
OBJECTIVES: To explore associations of psychiatric comorbidity with rehospitalization risk, 2 
length of hospitalization, and costs.  3 
DESIGN:  Cross-sectional study of 1-year hospital administrative data.  4 
SETTING:  Claims-based study of older adults hospitalized in the United States. 5 
PARTICIPANTS:  21,429 patients from a 5% national random sample of U.S. Medicare 6 
beneficiaries, aged 65 and older, with at least one acute care hospitalization in 1999 with a 7 
Diagnostic-Related Group of Congestive Heart Failure. 8 
MEASUREMENTS: The number of hospitalizations, mean length of hospital stay, and total 9 
hospitalization costs in calendar year 1999. 10 
RESULTS:  Overall, 15.82% of patients hospitalized for heart failure had a coded psychiatric 11 
comorbidity; the most commonly coded comorbid psychiatric disorder was depression (8.5% of 12 
the sample). Most forms of psychiatric comorbidity were associated with increases in inpatient 13 
utilization, including risk of additional hospitalizations, additional days of stay, and additional 14 
hospitalization charges. Additional hospitalization costs associated with psychiatric comorbidity 15 
ranged up to $7763 and additional days length of stay ranged up to 1.4 days.  16 
CONCLUSION:  Psychiatric comorbidity appears in a significant minority of patients 17 
hospitalized for heart failure and may affect their clinical and economic outcomes. The 18 
associations of psychiatric comorbidity with utilization of inpatient care are likely to be an 19 
underestimate because psychiatric illness is known to be underdetected in older adults and in 20 
hospitalized medical patients.  21 
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INTRODUCTION 25 
Currently, over 5 million Americans have heart failure,1 with increasing prevalence in older 26 
cohorts of adults, largely due to the aging U.S. population and increased survival of patients with 27 
heart failure. Despite medical advances2 and the positive impact of heart failure management 28 
programs,3 the cost of care for heart failure remains high. Heart failure is responsible for $33.2 29 
billion in health care costs in the U.S., approximately 1.5% of total health care expenditure.3 30 
Hospitalizations account for 65% of the costs of treating heart failure.3  31 
There is significant evidence that comorbid psychiatric disorders contribute to increased 32 
risk of hospitalization among patients with heart failure and increased costs of these 33 
hospitalizations.4 Depression is common among hospitalized older adults with heart failure,5 and 34 
likely leads to increased outpatient utilization, higher health care costs, and to a doubled risk of 35 
rehospitalization and death within 1 year.6 Few studies have examined the consequences of a broad 36 
range of psychiatric disorders for hospitalized older adults with heart failure (e.g., anxiety 37 
disorders, alcohol abuse), despite evidence of increased rates of these problems in the heart failure 38 
population.7 39 
The goal of this study was to examine the effects of identified comorbid psychiatric 40 
disorders on healthcare utilization and costs in a sample of Medicare beneficiaries hospitalized at 41 
least once with a primary diagnosis of heart failure in 1999. Our major hypothesis was that having 42 
a psychiatric disorder would be associated with increased rates of hospitalization, length of 43 
hospitalizations, and hospitalization costs in older adults with heart failure. Consistent with 44 
existing findings we hypothesized that identified comorbid psychiatric disorders might vary across 45 
groups defined by gender, socioeconomic status,8 and race9 and that these variables, as well as 46 
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medical comorbidities, would require controls in our models examining the association between 47 
psychiatric comorbidities and health care utilization. 48 
49 
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METHODS 50 
Study Sample 51 
 The study sample was drawn from a 5% random national sample of Medicare beneficiaries 52 
hospitalized during the 1999 calendar year. Using the Denominator and MedPAR files obtained 53 
from the Center for Medicaid and Medicare Services (CMS), we extracted records of 54 
hospitalizations in 1999 that were assigned the Congestive Heart Failure Diagnostic-Related 55 
Grouping (DRG 127). Records of different hospitalizations for the same patients were then 56 
collapsed so that the patient became the unit of analysis for most analyses. Because we used 57 
hospital DRGs to identify target patients, we excluded patients for whom heart failure was not a 58 
primary cause of any admission during 1999, even though it might have been a contributory cause 59 
for an admission during that year. This approach was used to limit the extent to which we included 60 
patients without a chronic heart failure condition. We excluded patients with comorbid dementia or 61 
organic brain syndrome diagnosis from the sample because they might exhibit less variability in 62 
their clinical course and the associated costs compared to those with other psychiatric 63 
disturbances.10, 11 64 
Of the 5% national sample of 357,232 unique patients, a total of 27,949 patients had a CHF 65 
DRG during at least one of their hospitalizations for that year. About one-fifth of these patients 66 
were excluded due to dementia or organic brain syndrome (n=3,123, 11.1%), or an age less than 65 67 
years (n=2,628, 9.4%) because persons younger than 65 years may have qualified for Medicare 68 
coverage on the basis of physical or mental disability. A further 2.8% (n = 769) were excluded on 69 
the basis of having been admitted before the year 1999, hospitalization costs suggesting data entry 70 
errors, or stays longer than 365 days suggestive of long-term care rather than acute 71 
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hospitalizations. The final sample included 21,429 individuals with a CHF DRG for at least one of 72 
their hospital stays during the year 1999. 73 
Measures 74 
We used the definitions of medical comorbidity indices as described by Elixhauser and 75 
colleagues12 and used their algorithm as applied in publicly-available software code distributed by 76 
the Agency for Healthcare Research and Quality (AHRQ).13 The algorithm places emphasis on 77 
comorbidities that could increase resources used or the risk of poor outcomes that are not directly 78 
related to the reason for admission.12 Because of our focus on heart failure, it was not analyzed as a 79 
separate comorbidity in our analyses. 80 
For the current study we expanded Elixhauser and colleagues’12  categories of comorbid 81 
psychiatric disorders based on the initial work by Hanrahan,14 as well as evidence for inclusion of 82 
disorders not represented in the system.7 Psychiatric diagnoses within each category were 83 
identified using AHRQ’s Clinical Classifications Software15 (available from the first author upon 84 
request). Our final list of psychiatric comorbidity categories was as follows: alcohol abuse, drug 85 
abuse, psychosis, depression, bipolar disorders, anxiety disorders, and other psychiatric conditions. 86 
The variable we analyzed was presence vs. absence in any hospitalizations in 1999 of each type of 87 
comorbid medical and psychiatric condition. 88 
The following demographic variables were analyzed: age, gender, and race. In addition, we 89 
used the receipt of Medicaid benefits anytime during the year 1999 as a proxy for socioeconomic 90 
status because so-called “dual” eligibility for Medicaid and Medicare requires falling below 91 
poverty levels defined by the U.S. Department of Health and Human Services.16 92 
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Our primary health care utilization and outcome included the patient’s total number of 93 
hospitalizations in 1999, average length of stay (LOS) of all hospitalizations in 1999, and total 94 
hospitalization charges in 1999. All indices were collapsed across patients’ hospitalizations for the 95 
year and represented the values for individual patients. 96 
Statistical Analyses 97 
Rates of psychiatric comorbidity were calculated, along with 95% confidence intervals. 98 
Relative proportions of the sample of patients with psychiatric diagnosis by gender, race, and low-99 
income status were examined using 2 X 2 chi-square tests. The continuous outcomes of number of 100 
hospitalizations, average LOS, and total charges were all markedly positively skewed, but after 101 
logarithmic data transformation they approximated the normal distribution. These transformations 102 
were reversed for presentation purposes in the tables. The data were evaluated for amount, 103 
distribution, and patterns of missing data, out-of-range values, plausible means, and univariate 104 
outliers. Missing values were randomly scattered throughout and were less than 5% of the data 105 
points. Cases with incomplete data on the variables relevant for each analysis were dropped. Group 106 
differences were examined using t-tests and Satterthwaite’s17 method for estimating degrees of 107 
freedom for unequal variances where appropriate. 108 
Presence of each type of psychiatric comorbidity was tested as a predictor of each outcome 109 
using regression modeling where the patient was the unit of analysis. Generalized linear modeling 110 
was used to test the hypothesis that psychiatric comorbidity explained a greater number of 111 
hospitalizations, mean LOS, and total hospitalization charges. Each of these analyses included the 112 
binomial variables (presence/absence) of each type of medical comorbidity as defined by 113 
Elixhauser et al.,12 entered as a block along with the expanded psychiatric comorbidity 114 
categories. Because the continuous outcomes of hospitalizations, average LOS, and total charges 115 
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were all positively skewed, we considered log transformation, but we were concerned about 116 
retransformation bias. In order to select the correct model, we examined the distributions of the 117 
log-scale residuals from GLM models with a log link function following the method of Manning 118 
and Mullahy.18 There was little kurtosis on the log-scale residuals (i.e., kurtosis < 3) so we chose 119 
GLM over ordinary least squares regression.  Modified Park tests on the raw-scale residuals 120 
indicated that λ=2 for each outcome, so the gamma family was selected for the final GLM models. 121 
To illustrate the impact of comorbidities on the outcome variables, estimates of effects of all 122 
comorbidity parameters from these models were transformed from the log values used for the 123 
analysis and then presented in a table. For parameters that were statistically significant, entries 124 
tabled were calculated using the parameter estimate for each effect and the intercept values of the 125 
major outcomes of interest that resulted from the significant model. 126 
127 
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RESULTS 128 
Sample characteristics  129 
 Table 1 presents the demographic and clinical characteristics of the final sample of 21,429 130 
heart failure patients. Over half of the patients were female (58.8%), and most were white (84.9%), 131 
and all were at least 65 years of age. Approximately one-fifth of the sample was designated as low-132 
income and 33.8% died during the 1999 year. As shown in Table 1, the mean total hospitalization 133 
charges was $40,048 but this outcome was highly skewed—the median value was $22,934. 134 
Prevalence of psychiatric comorbidities in the sample 135 
Table 2 presents prevalence estimates of identified psychiatric comorbidity, drawn from 136 
every hospitalization of each patient in the sample. A significant minority of patients had at least 137 
one psychiatric comorbid condition recorded. Within this subset of patients, 15.8% (N=518) of 138 
patients had 2 or more different psychiatric diagnoses within or across any of their hospitalizations 139 
in that year. However, these patients did not have systematically greater patterns of hospitalization 140 
utilization. Those with more than one psychiatric diagnosis, compared to those with only one, had 141 
a greater number of hospitalizations, M = 5.5, SD = 3.4, vs. M = 4.0, SD = 2.6, t(639) = 9.86, p < 142 
.0001, but lower average costs per hospitalization, M = $11,845, SD = $8,566, vs. M = $12,914, 143 
SD = $10,766, t(835) = -2.51, p < .05. The two groups did not differ on the mean length of 144 
hospitalizations, M = 8.8, SD = 6.1, vs. M = 8.6, SD = 7.5, t(835) = 0.58, p > .05.  145 
Psychiatric comorbidities in relation to gender, socioeconomic status, and race 146 
Women were more likely than men to have a comorbid psychiatric diagnosis, 16.8% vs. 147 
13.3%, χ2[1] = 48.82, p < .0001, N = 21,429. Depression and anxiety disorders were more 148 
common in women (10.0% vs. 6.3%, χ2[1] = 89.77,  and 5.0% vs. 2.1%, χ2[1] = 114.01, 149 
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respectively, both p’s < .0001). Male patients were more likely than female patients to have an 150 
alcohol abuse diagnosis (2.5% vs. 0.5%, χ2[1] = 157.57, p < .0001). No differences in rates of 151 
bipolar disorder, psychoses, drug abuse, or other psychiatric problems were observed by gender.  152 
A higher proportion of low-income beneficiaries had psychiatric diagnoses, compared to all 153 
other beneficiaries, 18.7% vs. 14.4%, χ2[1] = 50.74, p < .0001, N = 21,429. Specifically, more 154 
low-income patients had diagnoses of psychosis (3.4% vs. 2.2%, χ2[1] = 21.38, p < .0001), 155 
depression (10.1% vs. 8.1%, χ2[1] = 18.33, p < .0001), drug abuse (0.9% vs. 0.5%, χ2[1] = 10.36, p 156 
< .005), anxiety disorders (4.7% vs. 3.6%, χ2[1] = 14.17, p < .001), and other psychiatric diagnoses 157 
(1.8% vs. 1.0%, χ2[1] = 21.24, p < .0001). There were no differences in the likelihood of bipolar 158 
disorder or alcohol abuse disorders by income status. 159 
Proportionally more White patients had a recorded psychiatric diagnosis than non-White 160 
patients (Black and other non-White categories combined), 15.8% vs. 12.4%, χ2[1] = 23.25, p <  161 
.0001). Fewer Black patients had psychiatric diagnoses than those in the White or other race 162 
categories combined, 12.5% vs. 15.7%, χ2[1] = 16.3, p < .0001. 163 
Psychiatric comorbidities as predictors of outcomes 164 
Number of hospitalizations. Consistent with our hypotheses, all types of psychiatric 165 
comorbidity were associated with a greater risk of hospitalizations, χ2(38) = 4008.30, p < .0001, 166 
after adjusting for medical comorbidities (see Table 3). All forms of psychiatric comorbidity were 167 
associated with having at additional risk of hospitalization, ranging from .20 to .39 additional 168 
hospitalizations, on average. Sensitivity analyses excluding patients who had died during 1999 169 
revealed very similar findings indicating no significant effects due to an increase in number of 170 
hospitalizations at end of life. 171 
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Follow-up analyses indicated psychiatric comorbidity was associated with increased risk of 172 
hospitalizations specifically attributed to heart failure exacerbation (i.e., with a DRG of heart 173 
failure). The mean heart failure hospitalizations for patients with psychiatric comorbidity versus no 174 
psychiatric comorbidity, were M=1.59 (SD=1.11), M=1.35 (SD=.80) and respectively, t(3921)= -175 
12.16, p < .0001.  176 
 Mean length of stay (LOS). In partial support of our hypothesis, alcohol abuse, psychoses, 177 
major depression, and bipolar disorder were significant predictors of increased mean LOS, after 178 
adjusting for the effects of all significant types of medical comorbidity, χ2 (38) = 1383.76, p < 179 
.0001. Significantly, having bipolar disorder as a comorbid diagnosis was associated with 1.4 180 
additional days of stay per hospitalization on average, holding other factors constant. The effects 181 
of each type of psychiatric comorbidity were independent of each other and were similar in 182 
magnitude when tested individually, indicating no significant multicollinearity effects. Sensitivity 183 
analyses showed no impact of excluding patients who died during the study year, suggesting that 184 
the findings could not be attributed to an “end-of-life” effect. 185 
Total hospital charges. Consistent with our hypotheses, psychiatric comorbidities, as a 186 
group, were associated with higher total hospitalization costs, χ2 (38) = 7294.32, p < .0001. As 187 
shown in Table 3, the additional hospitalization costs specifically attributable to each diagnosis, 188 
ranged from $1,8433.89 - $7,763.47. Again, parallel analyses indicated that the effects of 189 
psychiatric comorbidity were not dependent on the multicollinearity of the variables. Sensitivity 190 
analyses indicated no effect associated with hospital charges by patients at the end of life. 191 
192 
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DISCUSSION 193 
These findings represent the first comprehensive examination of psychiatric comorbidity 194 
and hospitalizations of older patients with heart failure. We have presented evidence that the 195 
negative effects of depression on the course of heart failure19 may extend to other psychiatric 196 
disturbances. In a nationally representative sample we showed that psychiatric comorbidity was 197 
prevalent in Medicare recipients hospitalized for heart failure, with depression being the most 198 
common form. All forms of psychiatric comorbidity were associated with risk of additional 199 
hospitalizations comparable to medical comorbidities within a 1-year period and that the presence 200 
of alcohol abuse, depression, bipolar disorder, or psychoses predicted longer hospitalizations. All 201 
forms of psychiatric comorbidity were associated with increased health care costs that were at least 202 
comparable to other major forms of chronic illness. For example, diabetes with chronic 203 
complications was associated with 30% increased costs; depression and bipolar disorder were 204 
associated with cost increases of 25% and 52%, respectively. Analyses reported in this paper 205 
accounted for the effects of medical comorbidities using a method developed specifically to adjust 206 
for their impact on health care utilization, costs, and illness burden.12  207 
There are several potential explanations for these effects. Heavy cardiac and noncardiac 208 
comorbidities in older adults with heart failure complicates their treatment.20 It may be more 209 
difficult to stabilize patients who are depressed or psychotic, and the functional disability 210 
associated with these conditions is a barrier to effective treatment.21 Those with psychiatric 211 
disturbances have poorer treatment adherence and self-care.22 There is also evidence that even 212 
when psychiatric disturbances are recognized and initially treated in medical contexts, the 213 
psychiatric outcomes of these patients are no better than those who had psychiatric disturbance 214 
 14 
 
unrecognized by their medical providers. 23, 24 Thus, research and clinical innovation will be 215 
needed to address the challenge of treating psychiatric problems in medical settings.  216 
In addition, activation of the hypothalamic-pituitary-adrenocortical axis associated with 217 
psychiatric disturbance may play a role in poorer course within and between hospitalizations, 218 
although this type of explanation has most typically been applied to the role of depression in 219 
cardiovascular outcomes.25 Our data do point to effects of psychiatric comorbidity on the course of 220 
HF, specifically; patients with psychiatric comorbidity had a greater number of HF 221 
hospitalizations. Although our data cannot specifically address the mechanisms involved, this is an 222 
important avenue for future research. 223 
Although out findings are similar to those of Braunstein and colleagues6 we used more 224 
restrictive criteria to identify patients with chronic heart failure (i.e., at least one hospitalization 225 
with a Congestive Heart Failure DRG). This likely resulted in a more severely ill patient sample. 226 
This restriction may explain why 35.3% of our sample died during the year on which the sample is 227 
based, compared to 18% of the sample defined by Braunstein. Our findings extend earlier work by 228 
showing that other psychiatric disorders in addition to depression have important associations with 229 
increased medical care utilization and costs.  230 
There were limitations resulting from the use of claims-based administrative data. There 231 
might have been positive and/or negative biases in diagnosis and medical record coders that 232 
resulted from sources such as payment incentives and stigma associated with psychiatric 233 
diagnoses.26 The diagnoses in the current study could not be validated against standardized criteria. 234 
Although other studies have reported adequate sensitivity and specificity for chart based 235 
psychiatric diagnoses in mental health settings,27 it is likely that diagnoses obtained from claims-236 
based records in the current study led to lower sensitivity for psychiatric disorders. Mood 237 
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disorders, and potentially other psychiatric problems, are significantly underdiagnosed and 238 
undertreated in older adults in medical settings.24 The rates of depression we reported are lower 239 
than in interview studies of carefully diagnosed patients hospitalized for heart failure (i.e., ranging 240 
from 20 – 37%).5, 28 In addition, the phenomenon of treatment of psychiatric disorders without 241 
chart documentation of a psychiatric disorder29 indicate that psychiatric difficulties in our sample 242 
could be higher than the chart-based rates suggest.  243 
No information was available regarding the severity of heart failure in the sample. 244 
However, our method of replicating analyses without patients who later died gave some control 245 
over illness severity. We cannot exclude the possibility that outcomes may be worse for patients 246 
with coded comorbid psychiatric diagnoses as opposed to the presence of the conditions 247 
themselves. In addition, only longitudinal designs, with more carefully diagnosed psychiatric 248 
conditions, can clarify the complex causal relationships between psychiatric conditions and the 249 
course of heart failure hospitalizations and outcomes.  250 
CONCLUSION 251 
Psychiatric comorbidity is prevalent among older adults with heart failure and our findings 252 
suggest that psychiatric illness has a demonstrable impact on the utilization of acute inpatient 253 
medical care. Future research should focus on the how this effect occurs. Important changes in 254 
clinical practice with these patients may include routine screening for psychiatric disorder and 255 
increased access to pharmacological as well as cognitive-behavioral interventions, with 256 
modifications based on the needs of older adults. Future research also should be focused on how 257 
best to identify and treat psychiatric disturbance in older patients with heart failure. This line of 258 
research has promise in reducing the burden of illness on older adults with heart failure, and in 259 
reducing the high costs of treating patients with this condition.  260 
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Table 1. Demographic and Clinical Characteristics of Patients in the 5% Sample 
With a CHF DRG At Any Hospitalization During 1999 
Characteristic     
Gender (N, %) Male 8830 41.2 
 Female 12599 58.8 
    
Race (N, %) White 18188 84.9 
 Black 2301 10.7 
 Other 940 4.4 
    
Low-income (N, %)  4637 21.6 
    
Age (M, SD) Male 77.5 7.2 
 Female 80.0 7.9 
    
Died during 1999 (N, %)  7571 35.3 
    
# of hospitalizations (M, SD)  2.96 2.20 
    
# of CHF hospitalizations (M, SD)  1.38 0.86 
    
Avg. Length of Stay (M, SD)  7.3 6.9 
    
Total Charges $ US  (M, SD)  40,048 52,916 
    
    
 294 
295 
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 297 
Table 2. Estimates of Psychiatric Comorbidity For Patients With Heart Failure DRG 
At Any Hospitalization During 1999 (N = 21,429) 
Type of Psychiatric Disorder N % 
95% confidence 
interval 
Any Psychiatric Disorder 3287 15.34  
     
Alcohol abuse 290 1.4   1.2-1.5 
     
Drug Abuse 122 0.6   0.5-0.7 
     
Psychosis 534 2.5   2.3-2.7 
     
Depression 1821 8.5   8.1-8.9 
     
Bipolar Disorders 58 0.3 0.2-0.3 
     
Anxiety Disorders 816 3.8 3.6-4.1 
     
Other Psychiatric Condition 243 1.1 1.0-1.3  
 298 
Note: A minority of patients received more than one type of psychiatric diagnosis in 1999. 299 
 300 
301 
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 302 
 303 
Table 3. Estimated Effects of Demographics, Medical and Psychiatric Comorbidities on Length of Stay, 
Number of Hospitalizations, and Total Hospitalization Charges For Patients With Heart Failure DRG (N = 
21,429) 
 
Estimated  
Additional Number  
(% change)  
of Hospitalizations 
Estimated Additional 
Mean Length of Stay  
(% change) in Days 
Additional Total 
Hospitalization Charges 
Estimate  
(US Dollars) 
       
Effect 
Parameter 
Estimate  
p 
value 
Parameter 
Estimate 
p 
value 
Parameter Estimate p 
value 
       
 
Demographics       
       
Age 70-79*          — .408 0.39 (+ 9%) <.0001 -1001.29 ( -7%) .006 
       
Age 80-89* 0.09 (+7%) <.0001 1.37 (+31%) <.0001 -1662.65 (-11%) <.0001 
       
Age 90+* 0.15 (+11%) <.0001 2.30 (+51%) <.0001 2827.77 (+19%) <.0001 
       
Female -0.03 (-2%) .016 0.39 (+ 9%) <.0001 -813.87 ( -5%) .001 
       
Black race** -0.09 (-7%) <.0001 — .713 — .159 
       
Other race** — .317 — .101 3261.55 (+22%) <.0001 
       
Medicaid 0.08 (+6%) <.0001 0.37 (+ 8%) <.0001 — .682 
       
Medical Comorbidities 
Hypertension 0.39 (+30%) <.0001 -0.30 (- 7%) <.0001 5295.26 (+35%) <.0001 
       
Valvular Disease 0.21 (+16%) <.0001 — .455 4901.10 (+33%) <.0001 
       
Pulmonary Circulation Disease 0.17 (+13%) <.0001 0.38 (+ 9%) <.0001 2806.30 (+19%) <.0001 
       
Peripheral Vascular Disease 0.29 (+23%) <.0001 0.24 (+ 5%) .003 4320.65 (+29%) <.0001 
       
Paralysis 0.40 (+31%) <.0001 1.75 (+39%) <.0001 6613.03 (+44%) <.0001 
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Other Neurological Disorders 0.22 (+17%) <.0001 1.06 (+24%) <.0001 3987.54 (+27%) <.0001 
       
Chronic Pulmonary Disease 0.30 (+23%) <.0001 0.45 (+10%) <.0001 5548.66 (+37%) <.0001 
       
Diabetes without Chronic 
Complications 0.16 (+12%) <.0001 — .08 1731.00 (+12%) <.0001 
       
Diabetes with Chronic 
Complications 0.27 (+21%) <.0001 0.81 (+18%) <.0001 4784.63 (+32%) <.0001 
       
Hypothyroidism 0.16 (+13%) <.0001 — .102 2390.93 (+16%) <.0001 
       
Renal Failure 0.22 (+17%) <.0001 0.39 (+ 9%) <.0001 3993.25 (+27%) <.0001 
       
Liver Disease 0.23 (+18%) <.0001 0.53 (+12%) .035 2506.64 (+17%) .019 
       
Lymphoma 0.15 (+12%) .004 — .772 2854.62 (+19%) .019 
       
Peptic Ulcer Disease and 
Bleeding — .141 — .777 — .723 
       
Metastatic Cancer 0.29 (+23%) <.0001 0.65 (+14%) .002 3801.28 (+25%) <.0001 
       
Solid tumor without Metastasis 0.31 (+24%) <.0001 — .311 4355.15 (+29%) <.0001 
       
Rheumatoid arthritis/ Collagen 
Vascular Diseases 0.27 (+21%) <.0001 0.71 (+16%) <.0001 3330.07 (+22%) <.0001 
       
Coagulation Deficiency 0.24 (+19%) <.0001 0.82 (+18%) <.0001 8465.06 (+56%) <.0001 
       
Obesity 0.15 (+12%) <.0001 0.41 (+ 9%) .002 1896.18 (+13%) .001 
       
Weight Loss 0.36 (+28%) <.0001 1.91 (+43%) <.0001 11497.23 (+76%) <.0001 
       
Fluid and electrolyte Disorders 0.43 (+33%) <.0001 0.83 (+18%) <.0001 7381.35 (+49%) <.0001 
       
Chronic Blood Loss Anemia 0.31 (+24%) <.0001 0.33 (+7%) .021 4485.02 (+30%) <.0001 
       
Deficiency Anemias 0.30 (+24%) <.0001 0.22 (+5%) .001    4202.99 (+28%) <.0001 
       
Acquired Immune Deficiency 
Syndrome — .307 — .744 — .478 
       
Psychiatric Comorbidities 
Alcohol abuse 0.21 (+16%) <.0001  0.58 (+13%) .026 3461.25 (+23%) .002 
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Drug Abuse 0.32 (+25%) <.0001 — .819 3723.24 (+25%) .031 
       
Psychoses 0.30 (24%) <.0001 1.06 (+24%) <.0001 3611.95 (+24%) <.0001 
       
Depression 0.39 (+30%) <.0001 0.89 (+20%) <.0001 3815.85 (+25%) <.0001 
       
Bipolar Disorders 0.38 (+30%) .001 1.43 (+32%) .021 7763.47 (+52%) .005 
       
Anxiety Disorders 0.34 (+27%) <.0001 — .371 1843.89 (+12%) .005 
       
Other Psychiatric Condition 0.37 (+29%) <.0001 — .702 3694.33 (+25%) .003 
 304 
Notes:  305 
Entries in Table 3 were calculated from GLM models and presented as actual hospitalizations, average LOS 306 
in days, and total charges for ease of interpretation following the methods of Zhou, Stroupe and 307 
Tierney30. For parameters that were statistically significant, estimates represent the increased/decreased 308 
utilization associated with the characteristic, in relation to the intercept value. In addition, the percent 309 
increase in the estimate relative to the intercept value is also presented. The intercept values for the 310 
outcomes in the table were as follows: 1.28 hospitalizations, 4.47 days of length of stay, and total charges of 311 
$15,037.21. 312 
 313 
* Age 65-69 is reference category. 314 
**White race is reference category. 315 
 316 
 317 
318 
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